Clinical Trial Update: PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer [NA]

View source ↗

Summary

A clinical trial is evaluating a PD-1 inhibitor in combination with progesterone as a fertility-sparing treatment for mismatch repair-deficient endometrial canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Endometrioid Carcinoma

Drugs mentioned

• PD-1 inhibitor
• PROGESTERONE (Progesterone)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Endometrial Cancer, Endometrioid Carcinoma | NA | Status: NOT_YET_RECRUITING